• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: GENEOHM SCIENCES CANADA, INC. (BD DIAGNOSTICS) BD MAX CT/GC/TV; TRICHOMONAS VAGINALIS NUCLEIC ACID AMP .TEST SYS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

GENEOHM SCIENCES CANADA, INC. (BD DIAGNOSTICS) BD MAX CT/GC/TV; TRICHOMONAS VAGINALIS NUCLEIC ACID AMP .TEST SYS Back to Search Results
Model Number 442970
Device Problem False Positive Result (1227)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 03/22/2021
Event Type  malfunction  
Manufacturer Narrative
A device evaluation is anticipated, but has not yet begun.Upon completion of the investigation, a supplemental report will be filed.
 
Event Description
It was reported while using bd max¿ ct/gc/tv a false positive for gc was obtained.Sample was recollected and retested and the result was negative.There was no report of additional patient impact.The following information was provided by the initial reporter: max ctgctv discrepant result; reported by mas on instrument initial gc positive result disputed and recollect sample result was gc negative position a8 (endocervical patient sample) -initial result ct neg, gc pos, tv neg; customer states sample repeated and all results matched; positive gc result reported and result disputed; recollection of endocervical sample from same patient and tested on ct2112 with ctgctv (lot k58028237020211109), run 22 (4/1/2021), position b3 ¿ recollect sample results all negative for ct, gc, and tv;.
 
Manufacturer Narrative
H.6.Investigation: the complaint investigation for discrepant results when using the bd max ct/gc/tv (ref 442970) lot 0350755 was performed by the review of manufacturing records, review of customer¿s data and verification of complaints history.Review of the manufacturing records of the bd max ct/gc/tv indicated that lot 0350755 was manufactured according to specifications and met performance requirements.Customer complained about one gc positive result that was positive on the initial test (run 16) and upon retest (data not provided).The gc positive result was considered suspicious by the customer and a new sample was recollected for a retest.Negative result was obtained with the new sample (run 22).Customer provided two run files (runs 16 and 22) from instrument ct2112 for investigation.Manual pcr curve adjudication was performed on the discrepant samples.Manual curve adjudication has limitations; visual examination of pcr curves for low signal and/or aberrant curve geometry is an extremely conservative assessment of the data.Analysis of the pcr curves shows true but low amplification without anomaly indicative of true positive results.Low positive samples can occur due to viral titers in the specimen being at or near the limit of detection (lod) of the assay or through environmental or cross contamination introduced during the sample preparation at the customer¿s site.Bd was unable to confirm the exact cause of the customer¿s discrepant results.Overall, no product issue is suspected.There is no indication of an increase in complaints for discrepant results for the bd max ct/gc/tv lot 0350755.The root cause was not identified but positives samples at the limit of detection of the assay and/or contamination by customers are suspected.Bd cannot confirm the complaint based on the investigation that was performed.Bd did not initiate a corrective and preventive action (capa).Bd apologizes for the inconvenience that this may have caused.Bd quality will continue to monitor for trends.
 
Event Description
It was reported while using bd max¿ ct/gc/tv a false positive for gc was obtained.Sample was recollected and retested and the result was negative.There was no report of additional patient impact.The following information was provided by the initial reporter: max ct, gc, tv discrepant result; reported by mas on instrument initial gc positive result disputed and recollect sample result was gc negative position a8 (endocervical patient sample) -initial result ct neg, gc pos, tv neg; customer states sample repeated and all results matched; positive gc result reported and result disputed; recollection of endocervical sample from same patient and tested on ct2112 with ct, gc, tv (lot k58028237020211109).Run 22 ((b)(6) 2021), position b3 ¿ recollect sample results all negative for ct, gc, and tv.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
BD MAX CT/GC/TV
Type of Device
TRICHOMONAS VAGINALIS NUCLEIC ACID AMP .TEST SYS
Manufacturer (Section D)
GENEOHM SCIENCES CANADA, INC. (BD DIAGNOSTICS)
2555 blv. du parc techn
quebec
MDR Report Key11755580
MDR Text Key268260210
Report Number3007420875-2021-00014
Device Sequence Number1
Product Code OUY
UDI-Device Identifier00382904429706
UDI-Public00382904429706
Combination Product (y/n)N
PMA/PMN Number
K151589
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type other,user facility
Type of Report Initial,Followup
Report Date 07/12/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Other
Device Expiration Date12/21/2021
Device Model Number442970
Device Catalogue Number442970
Device Lot Number0350755
Was Device Available for Evaluation? No
Initial Date Manufacturer Received 04/06/2021
Initial Date FDA Received04/30/2021
Supplement Dates Manufacturer Received07/12/2021
Supplement Dates FDA Received07/27/2021
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
-
-